All Episodes
Displaying 1 - 20 of 42 in total
Heart Pump Trials Question Routine Use; Caris Detect Advances; Genomic Testing Tackles Disparities
In this episode, we delve into recent findings from the American College of Cardiology’s annual meeting, where Johnson & Johnson's Impella heart pump was shown to offe...
UCSB's MRI Breakthrough, Labcorp's Expansion, AI in Genomics, UK Drug Pathway, Ohio's Biomanufacturing Boost, Blackstone's Record Fund, IO Biotech Bankruptcy
In this episode, we explore groundbreaking developments in the life sciences and healthcare sectors. Researchers at the University of California, Santa Barbara, have u...
Unlocking Biotech's Future: AI, Atrandi's Innovations, and Generative AI in Drug Discovery
In this episode, we delve into the transformative power of the data multiplier effect in the biotech sector, as reported by Fierce Biotech. By integrating expertise, m...
2026 MedTech M&A Surge, Nona's Immunology Push, Stellaromics' Brain Research, and AI in Biotech
In this episode, we explore the dynamic landscape of the medical device industry as it heads into 2026, with mergers and acquisitions taking center stage. We discuss B...
Neuralink's Telepathy Trials, BD-Waters Merger, AI Street Medicine, and Boehringer's Kidney Breakthrough
In this episode, we delve into Neuralink's groundbreaking clinical trials with 21 "Neuralnauts" using the Telepathy device, allowing quadriplegics to control devices t...
Medtronic & Mindray Boost ASCs; Mair Targets Parkinson's; AI in GI; Aging Study; Organoids in Neuroscience
In this episode, we explore the latest developments in healthcare and biotechnology. Medtronic expands its collaboration with Mindray to integrate patient monitoring t...
Medtronic's Sphere-360 CE Mark, Parkinson's Precision Therapies, and BBB Breakthroughs
In this episode, we explore Medtronic's recent CE mark approval for its Affera Sphere-360 pulsed field ablation catheter, designed to treat paroxysmal atrial fibrillat...
Integra Recall, Curant-Cencora Partnership, AION Labs AI, NICE DHTs, Cellular Origins Update
In this episode, we cover several significant developments in the healthcare and pharmaceutical industries. Integra LifeSciences has recalled certain wound and burn tr...
Dawnzera's EU Approval, Medtronic's Investment in Anteris, and DEI Trends in Life Sciences
In this episode, we explore the latest developments in the healthcare and pharmaceutical industries. The European Commission has approved Otsuka's Dawnzera for prevent...
Congress Reforms PBM & Telehealth; Boston Scientific Acquires Penumbra; Zydus Expands in Biologics
In this episode, we delve into Congress's landmark health care agreement targeting pharmacy benefit management reforms, telehealth expansion, and increased science fun...
Genes & Vision: New Study; AI in Biopharma; Biotech Geopolitics; Lilly-NVIDIA Lab; Cell Therapy Boost
In this episode, we delve into a groundbreaking study published in 2026 that challenges long-held beliefs about the genetic causes of vision impairment. The research r...
Telangana's Life Sciences Leap, US Biotech Challenges, Lilly-NVIDIA AI Lab, Illumina's Atlas
In this episode, we explore key developments in the global life sciences and biotech sectors. Telangana is set to unveil its Next-Generation Life Sciences Policy 2026–...
Medicaid Expansion Boosts Lung Cancer Survival; Mavacamten Shows Promise in Pediatric Cardiology
In this episode, we explore a range of recent developments in healthcare and technology: 1. A study highlights the positive impact of Medicaid expansion on lung cancer...
Biotech Moves at JPM 2026: AI Alliances, Funding Boosts, and NVIDIA's Billion-Dollar Lab Initiative
In this episode, we explore key developments from the JPMorgan Healthcare Conference, where biotech companies made waves despite the lack of major announcements, highl...
AI, Data, and Capital: Transforming Life Sciences with Accenture, Salesforce, Phreesia & More
In this episode, we explore how data, AI, and capital are transforming the life sciences industry as 2026 begins. We start with Accenture and Salesforce's new AI-power...
FDA Eases Device Rules; Eli Lilly's $1.2B Ventyx Deal; AI's Role in Pharma and Healthcare
In this episode, we explore the FDA's new guidance exempting certain wellness features and clinical decision support tools from medical device oversight, fostering inn...
Trump Urges GOP Flexibility on Abortion; Biobeat's Cuffless Monitor & Insilico-Servier AI Deal
In this episode, we delve into recent developments in politics, health care, and technology. Former President Donald Trump has called on Republicans to adopt a more fl...
AI in Health: ChatGPT Health Launch, Surgerii Robotics Funding, and Eli Lilly's Strategic Moves
Welcome to today's episode, where we explore the latest in health and technology. OpenAI has launched ChatGPT Health, a new feature designed to integrate personal heal...
Trump's AI Order Unifies Policy; Biotech Stocks & Medicare Telehealth Flexibility in Focus
In this episode, we explore President Donald Trump's recent executive order establishing a unified national policy for AI development, aiming to override various state...
AI in Pharma: Insilico's Breakthrough, Hospital Tech Dilemma, and DEA's Telehealth Extension
In this episode, we explore the transformative role of AI in the pharmaceutical industry, highlighting Insilico Medicine's Rentosertib, the first AI-discovered drug po...